Dyne Therapeutics, Inc. (DYN) has been on a downward spiral lately with significant selling pressure. After declining 42.2% over the past four weeks, the stock looks well positioned for a trend ...
Don has covered news and current affairs stories about the island countries and territories of the Pacific for more than 16 years, seen some of them; loved them; been daunted by them; met many ...